MetaADEDB 2.0 @ LMMD
Vena cava filter insertion
(UMLS:C0877093)
UMLS ID:
C0877093
MeSH ID:
N/A
Synonym(s)
1.
Vena cava filter insertion
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1NuvaRingFAERS: 119US FAERS
2RivaroxabanFAERS: 6US FAERS
3Sitagliptin PhosphateFAERS: 5US FAERS
4WarfarinFAERS: 4US FAERS
5RosiglitazoneFAERS: 3US FAERS
6apixabanFAERS: 3US FAERS
7pazopanibFAERS: 3US FAERS
8AlendronateFAERS: 2US FAERS
9BosentanFAERS: 2US FAERS
10DeferasiroxFAERS: 2OFFSIDES
US FAERS
11GabapentinFAERS: 2US FAERS
12IloprostFAERS: 2US FAERS
13WarfarinFAERS: 2US FAERS
14ambrisentanFAERS: 2US FAERS
15niraparibFAERS: 2US FAERS
16reviparinFAERS: 2OFFSIDES
US FAERS
17EstradiolFAERS: 1US FAERS
18FondaparinuxFAERS: 1OFFSIDES
US FAERS
19LevetiracetamFAERS: 1OFFSIDES
US FAERS
20RanitidineFAERS: 1US FAERS
21AlprostadilOFFSIDES
22BenztropineOFFSIDES
23BumetanideOFFSIDES
24CarboplatinOFFSIDES
25CeftriaxoneOFFSIDES
26CelecoxibOFFSIDES
27ChlorhexidineOFFSIDES
28ClonazepamOFFSIDES
29DicloxacillinOFFSIDES
30DocetaxelOFFSIDES
31DoxorubicinOFFSIDES
32LetrozoleOFFSIDES
33MelphalanOFFSIDES
34MepivacaineOFFSIDES
35MethylprednisoloneOFFSIDES
36MinoxidilOFFSIDES
37NaloxoneOFFSIDES
38NitrofurantoinOFFSIDES
39NizatidineOFFSIDES
40OxaprozinOFFSIDES
41PamidronateOFFSIDES
42Penicillin VOFFSIDES
43PerphenazineOFFSIDES
44RivastigmineOFFSIDES
45SertralineOFFSIDES
46SulfamethoxazoleOFFSIDES
47ThalidomideOFFSIDES
48VincristineOFFSIDES
49VinorelbineOFFSIDES
50Zoledronic AcidOFFSIDES
51alpha-TocopherolOFFSIDES
52bicalutamideOFFSIDES
53candesartan cilexetilOFFSIDES
54chlorhexidine gluconateOFFSIDES
55dolasetronOFFSIDES
56ethyl loflazepateOFFSIDES
57flomoxefOFFSIDES
58gemcitabineOFFSIDES
59perospironeOFFSIDES
60tegaserodOFFSIDES
61tegaserodOFFSIDES
62zopicloneOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.